Vascular Perfusion Solutions announced it raised $147 Million in an initial filing from an offering of $344 Million

Company

Location

About

Vascular Perfusion Solutions (VPS), a Texas-based early-stage Medtech company, is revolutionizing organ transplantation with a focus on simplicity, ease of use, and accessibility in price through our flagship product, the VP.S ENCORE®, a hypothermic machine perfusion device for prolonged cardiac graft preservation. This innovative device represents a groundbreaking advancement in heart preservation technology, surpassing conventional methods such as the ice-cooler. It has gained FDA breakthrough device designation in 2021 and undergone successful preclinical testing on over 100 hearts, including ovine, porcine, and human hearts donated for research.